# | Title | Journal | Year | Citations |
---|
1 | Chitin and Chitosan Preparation from Marine Sources. Structure, Properties and Applications | Marine Drugs | 2015 | 1,640 |
2 | Astaxanthin: Sources, Extraction, Stability, Biological Activities and Its Commercial Applications—A Review | Marine Drugs | 2014 | 1,323 |
3 | Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications | Marine Drugs | 2015 | 908 |
4 | Chemical Structures and Bioactivities of Sulfated Polysaccharides from Marine Algae | Marine Drugs | 2011 | 843 |
5 | Application of Spectroscopic Methods for Structural Analysis of Chitin and Chitosan | Marine Drugs | 2010 | 815 |
6 | Does the Use of Chitosan Contribute to Oxalate Kidney Stone Formation? | Marine Drugs | 2015 | 670 |
7 | Carotenoids in Algae: Distributions, Biosyntheses and Functions | Marine Drugs | 2011 | 617 |
8 | Neurotoxic Alkaloids: Saxitoxin and Its Analogs | Marine Drugs | 2010 | 604 |
9 | Stability of Chitosan—A Challenge for Pharmaceutical and Biomedical Applications | Marine Drugs | 2015 | 592 |
10 | Fucoxanthin, a Marine Carotenoid Present in Brown Seaweeds and Diatoms: Metabolism and Bioactivities Relevant to Human Health | Marine Drugs | 2011 | 587 |
11 | Chitosan Composites for Bone Tissue Engineering—An Overview | Marine Drugs | 2010 | 576 |
12 | High-Value Components and Bioactives from Sea Cucumbers for Functional Foods—A Review | Marine Drugs | 2011 | 567 |
13 | Marine Bioactives as Functional Food Ingredients: Potential to Reduce the Incidence of Chronic Diseases | Marine Drugs | 2011 | 564 |
14 | Chitosan in Plant Protection | Marine Drugs | 2010 | 545 |
15 | Important Determinants for Fucoidan Bioactivity: A Critical Review of Structure-Function Relations and Extraction Methods for Fucose-Containing Sulfated Polysaccharides from Brown Seaweeds | Marine Drugs | 2011 | 542 |
16 | Production of Chitooligosaccharides and Their Potential Applications in Medicine | Marine Drugs | 2010 | 496 |
17 | Microalgae as Sources of Carotenoids | Marine Drugs | 2011 | 477 |
18 | Marine Polysaccharides from Algae with Potential Biomedical Applications | Marine Drugs | 2015 | 477 |
19 | On the Chemistry, Toxicology and Genetics of the Cyanobacterial Toxins, Microcystin, Nodularin, Saxitoxin and Cylindrospermopsin | Marine Drugs | 2010 | 474 |
20 | Marine Polysaccharides in Pharmaceutical Applications: An Overview | Marine Drugs | 2010 | 464 |
21 | Bioactivity and Applications of Sulphated Polysaccharides from Marine Microalgae | Marine Drugs | 2013 | 444 |
22 | The Rising Tide of Antimicrobial Resistance in Aquaculture: Sources, Sinks and Solutions | Marine Drugs | 2017 | 444 |
23 | Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success | Marine Drugs | 2014 | 435 |
24 | Chitosan Modification and Pharmaceutical/Biomedical Applications | Marine Drugs | 2010 | 426 |
25 | Chitosan Based Polyelectrolyte Complexes as Potential Carrier Materials in Drug Delivery Systems | Marine Drugs | 2010 | 421 |
26 | Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications | Marine Drugs | 2016 | 408 |
27 | Antimicrobial Action of Compounds from Marine Seaweed | Marine Drugs | 2016 | 381 |
28 | Marine Drugs from Sponge-Microbe Association—A Review | Marine Drugs | 2010 | 360 |
29 | Recent Modifications of Chitosan for Adsorption Applications: A Critical and Systematic Review | Marine Drugs | 2015 | 359 |
30 | Chitins and Chitosans as Immunoadjuvants and Non-Allergenic Drug Carriers | Marine Drugs | 2010 | 358 |
31 | Microalgae for High-Value Products Towards Human Health and Nutrition | Marine Drugs | 2019 | 355 |
32 | Impact of Ocean Acidification on Energy Metabolism of Oyster, Crassostrea gigas—Changes in Metabolic Pathways and Thermal Response | Marine Drugs | 2010 | 347 |
33 | Antimicrobial Photodynamic Therapy: Study of Bacterial Recovery Viability and Potential Development of Resistance after Treatment | Marine Drugs | 2010 | 340 |
34 | Bacterial Exopolysaccharides from Extreme Marine Habitats: Production, Characterization and Biological Activities | Marine Drugs | 2010 | 332 |
35 | Marine Sponge Derived Natural Products between 2001 and 2010: Trends and Opportunities for Discovery of Bioactives | Marine Drugs | 2014 | 332 |
36 | Chitin Research Revisited | Marine Drugs | 2010 | 331 |
37 | Tetrodotoxin – Distribution and Accumulation in Aquatic Organisms, and Cases of Human Intoxication | Marine Drugs | 2008 | 326 |
38 | Marine Natural Products: A Source of Novel Anticancer Drugs | Marine Drugs | 2019 | 324 |
39 | Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug | Marine Drugs | 2016 | 323 |
40 | A Review of the Biological Activities of Microalgal Carotenoids and Their Potential Use in Healthcare and Cosmetic Industries | Marine Drugs | 2018 | 321 |
41 | Prebiotics from Marine Macroalgae for Human and Animal Health Applications | Marine Drugs | 2010 | 319 |
42 | Immense Essence of Excellence: Marine Microbial Bioactive Compounds | Marine Drugs | 2010 | 318 |
43 | Bioactive Compound Synthetic Capacity and Ecological Significance of Marine Bacterial Genus Pseudoalteromonas | Marine Drugs | 2007 | 316 |
44 | N-Acetylglucosamine: Production and Applications | Marine Drugs | 2010 | 314 |
45 | Biosorption: An Interplay between Marine Algae and Potentially Toxic Elements—A Review | Marine Drugs | 2018 | 308 |
46 | Actinomycetes for Marine Drug Discovery Isolated from Mangrove Soils and Plants in China | Marine Drugs | 2009 | 303 |
47 | Chitin Deacetylases: Properties and Applications | Marine Drugs | 2010 | 303 |
48 | Mycosporine-Like Amino Acids: Relevant Secondary Metabolites. Chemical and Ecological Aspects | Marine Drugs | 2011 | 303 |
49 | Carotenoids, Phenolic Compounds and Tocopherols Contribute to the Antioxidative Properties of Some Microalgae Species Grown on Industrial Wastewater | Marine Drugs | 2015 | 301 |
50 | Marine Origin Collagens and Its Potential Applications | Marine Drugs | 2014 | 300 |